BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 3 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,546 | +2.1% | 33,128 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $229,659 | +27.6% | 32,622 | +128.4% | 0.00% | 0.0% |
| Q3 2022 | $180,000 | -42.9% | 14,285 | -53.8% | 0.00% | 0.0% |
| Q1 2021 | $315,000 | -76.3% | 30,950 | -82.6% | 0.00% | -83.3% |
| Q4 2020 | $1,329,000 | +198.7% | 178,325 | +37.7% | 0.01% | +200.0% |
| Q3 2020 | $445,000 | +12.7% | 129,470 | +56.1% | 0.00% | 0.0% |
| Q2 2020 | $395,000 | +66.0% | 82,955 | -30.4% | 0.00% | 0.0% |
| Q1 2020 | $238,000 | -22.5% | 119,180 | +33.8% | 0.00% | 0.0% |
| Q4 2019 | $307,000 | +132.6% | 89,050 | +253.8% | 0.00% | +100.0% |
| Q3 2017 | $132,000 | +13.8% | 25,170 | +95.7% | 0.00% | 0.0% |
| Q1 2015 | $116,000 | – | 12,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $62,538,000 | 25.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,733 | $27,979,000 | 5.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 57,000 | $19,282,000 | 4.35% |
| MPM BioImpact LLC | 639,089 | $10,392,000 | 2.79% |
| Parkman Healthcare Partners LLC | 476,978 | $7,756,000 | 2.27% |
| Sarissa Capital Management LP | 1,390,790 | $22,614,000 | 2.14% |
| Ghost Tree Capital, LLC | 350,000 | $5,691,000 | 1.24% |
| Lisanti Capital Growth, LLC | 662,644 | $10,775,000 | 1.21% |
| Baker Brothers Advisors | 12,710,818 | $206,678,000 | 1.19% |
| Tamarack Advisers, LP | 125,000 | $2,033,000 | 0.96% |